Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Why Your Best Talent is Leaving and Four Ways to Win Them Back
By William A. Schiemann, Ph.D bio
Most leaders of companies today recognize the importance of having engaged people at work. Yet research from the Metrus Institute, Gallup, and others say that…
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
The big story of April wasn't any particular new deal but the apparent resolution of an old one—the Abbott-Alere merger. Deal volume remained…
23andMe Wins FDA Approval for DTC Genetic Test
...
Already a member? Log in here
CMS Enforcement Discretion Eases Pressure on Labs
...
Already a member? Log in here
FDA Exempts 71 Class I Device Types From 510(k) Filings
...
Already a member? Log in here
Abbott and Alere Reach New Deal Terms
From - Laboratory Industry Report
Abbott's deal to acquire Alere is back on. Both companies announced Friday, April 14, 2017, that they will move forward with the deal and have revised its terms…
Trump Budget “Blueprint”: 4 Ways It Will Impact Labs
...
Already a member? Log in here
Revised Travel Ban Issued
From - Laboratory Industry Report
We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order…
The 6 Things Labs Need to Know About the Trump Travel Ban
...
Already a member? Log in here